Abstract
Nanoparticles have an extensive range of diagnostic and therapeutic applications in cancer treatment. However, their current clinical translation is slow, mainly due to the failure to develop preclinical evaluation techniques that can draw similar conclusions to clinical outcomes by adequately mimicking nanoparticle behavior in complicated tumor microenvironments (TMEs). Microfluidic methods offer significant advantages over conventional in vitro methods to resolve these challenges by recapitulating physiological cues of the TME such as the extracellular matrix, shear stress, interstitial flow, soluble factors, oxygen, and nutrient gradients. The methods are capable of de-coupling microenvironmental features, spatiotemporal controlling of experimental sequences, and high throughput readouts in situ. This progress report highlights the recent achievements of microfluidic models to reconstitute the physiological microenvironment, especially for nanomedical tools for cancer treatment.
Original language | English |
---|---|
Article number | 2002122 |
Journal | Advanced Healthcare Materials |
Volume | 10 |
Issue number | 9 |
DOIs | |
Publication status | Published - 2021 May 5 |
Bibliographical note
Funding Information:This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2020R1A2B5B03002005 and 2020R1C1C1011255). N.W.C. was supported by the KIST Institutional Program (Project nos. 2E30080 and 2E30180).
Publisher Copyright:
© 2021 Wiley-VCH GmbH
Keywords
- drug screening
- in vitro tumor models
- microfluidics
- nanomedicine
- tumor microenvironments
ASJC Scopus subject areas
- Biomaterials
- Biomedical Engineering
- Pharmaceutical Science